论文部分内容阅读
来自法国国家健康与医学研究院(Institut National de la Sante et de la Recherche Medicale,INSERM),巴黎大学(University Paris Ren Descartes),上海交通大学瑞金医院中法遗传与生命科学实验室,瑞士路德维格癌症研究所(Ludwig Institute for cancer Research, LICR),美国国立卫生研究院等处的研究人员发现虽然之前认为Toll样受体(Toll-like receptors, TLRs)在抗病毒免疫中起广泛的作用,但是这一研究中TLR3看来只致力于保护身体不受一个具体病毒的感染,对其他病原体没有明显影响。这一研究成果公布在《Science》杂志上。
From the Institut National de la Sante et de la Recherche Medicale (INSERM), University Paris Ren Descartes, Shanghai Jiao Tong University Ruijin Hospital Sino-French Genetics and Life Science Laboratory, Ludwig, Switzerland Researchers at the Ludwig Institute for Cancer Research (LIC), the National Institutes of Health, and others have found that while Toll-like receptors (TLRs) were previously thought to play a wide-ranging role in antiviral immunity, However, TLR3 in this study appears to be dedicated solely to protecting the body from infection with a specific virus, with no apparent effect on other pathogens. The research results published in the “Science” magazine.